Soligenix, Inc. (SNGX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.37
- As of
Kresmion compiles this page from SNGX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
SOLIGENIX, INC. (SNGX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-21.
See the full SNGX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SNGX on one page. Preview it with sample data, then open it live with a free account.
Preview the SNGX dossierActive events for SNGX
- mediumEarnings above estimates
Q2-2026: Beat consensus by 24.1%, EPS $-0.12 vs $-0.1581 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in SNGX
- mediumEarnings above estimates
Q2-2025: Beat consensus by 12.6% - EPS $-0.82 vs $-0.9384 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 51.0% - EPS $-0.28 vs $-0.5712 estimate
FREE, NO ACCOUNT
Every event on SNGX, as it fires
New filings, 13F moves and cross asset events on SNGX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
SNGX positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 834223604 · 2026Q2 | $83K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SNGX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on SNGX
SNGX against its peers
SNGX's operating margin of -9923.2% ranks in the 32nd percentile of 10 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-04-30.
| Metric | SNGX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 119371 USD | 418189 USD | 43 | 14 |
| Gross margin | 0.0% | 35.3% | 25 | 5 |
| Operating margin | -9923.2% | -1291.4% | 32 | 10 |
| Net margin | -9282.3% | -465.4% | 29 | 11 |
| Return on equity | -209.4% | -205.3% | 47 | 17 |
Peers (20): LGVN, TRAW, CELZ, AZTR, SNTI, ACXP, PCSA, RVPH, PULM, BGMS, CANF, IMNN, ALZN, EVGN, JAGX, CDIO, SKYE, CSCIF, NIKI, VSBC. Left out: ADXN (period gap), LIANY (no annual filing), ENVB (no annual filing), XTLB (period gap), FBLG (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (SNGX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in SNGX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SNGX in the last 180 days.
Upstream: SEC EDGAR filings for SNGX
Kresmion, "SOLIGENIX, INC. (SNGX) institutional holdings and SEC filings", data as of 2026-09-21, https://kresmion.com/research/SNGX. Upstream data: SEC EDGAR filings for SNGX.
Link to this data (HTML):
<a href="https://kresmion.com/research/SNGX">SOLIGENIX, INC. (SNGX) institutional holdings and SEC filings (Kresmion)</a>
Follow SNGX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SNGX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.